Harry Hayter

Director, Key Accounts at GRAIL, Inc.

Harry Hayter is the Director of Key Accounts at GRAIL, Inc. Prior to this position, he served as Vice President of Business Development for Tempus, a healthcare software and analytics company that is building the world’s largest library of molecular and clinical data allowing us to power a machine-learning operating system that empowers physicians to make real-time, data-driven decisions for their cancer patients. Tempus’s system will allow healthcare stakeholders the ability to measure and manage the treatment of cancer in a way previously unseen. Harry has worked directly and indirectly with Specialty Pharmacy to develop strategies and process that improve the delivery of care in various disease states. Most recently, Harry worked for Foundation Medicine, United Therapeutics, Endo Pharmaceuticals and Takeda calling on Payors, SPx, PBMs and other associated stakeholders.

Meet the rest of the NASP board of directors and staff.